← Open Payments lookup

ASHLEY BOUKNIGHT: Open Payments

NPI 1205440351 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,713 in 129 payments from 16 companies in 2025. Trend: 2023 $1,619 · 2024 $1,895 · 2025 $2,713

Food & beverage: $2,419Consulting: $200Education: $94
CompanyPaymentsAmount
ABBVIE INC.57$1,137
Janssen Biotech, Inc.15$256
GENZYME CORPORATION8$234
Madrigal Pharmaceuticals7$193
Takeda Pharmaceuticals U.S.A., Inc.7$138
Lilly USA, LLC5$134
Gilead Sciences, Inc.6$99
Aimmune Therapeutics, Inc.4$97
Ipsen Biopharmaceuticals, Inc5$88
Regeneron Healthcare Solutions, Inc.3$77

Products named: RINVOQ, DUPIXENT, TREMFYA, REZDIFFRA, CREON, SKYRIZI, OMVOH, LINZESS.

Industry payments across OK — which companies pay providers there.